LEX 200 Pill - blue oval
Generic Name: sotagliflozin
Pill with imprint LEX 200 is Blue, Oval and has been identified as Inpefa 200 mg.
Inpefa is used in the treatment of Chronic Kidney Disease; Heart Failure; Type 2 Diabetes and belongs to the drug class SGLT-2 inhibitors. Inpefa 200 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for LEX 200
Inpefa
- Generic Name
- sotagliflozin
- Imprint
- LEX 200
- Strength
- 200 mg
- Color
- Blue
- Shape
- Oval
- Availability
- Prescription only
- Drug Class
- SGLT-2 inhibitors
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Manufacturer
- Lexicon Pharmaceuticals, Inc.
- National Drug Code (NDC)
- 70183-0221
See also:
Jardiance
Jardiance (empagliflozin) is used to treat type 2 diabetes, chronic kidney disease and reduce the ...
Farxiga
Farxiga (dapagliflozin) is an oral prescription medication that may be given to certain adults with ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Lasix
Lasix is a loop diuretic used to treat fluid retention from heart, liver, or kidney conditions, and ...
Rybelsus
Rybelsus tablets are used to improve blood sugar control in adults with type 2 diabetes, and may ...
Wegovy
Wegovy (semaglutide) an FDA-approved weekly injection for weight loss and to reduce heart risks ...
Kerendia
Kerendia is used for the treatment of patients with chronic kidney disease (CKD) associated with ...
Dapagliflozin
Dapagliflozin (Farxiga) is an SGLT2 inhibitor that is mainly used alongside diet and exercise to ...
Empagliflozin
Empagliflozin is used for cardiovascular risk reduction, chronic kidney disease, heart failure ...
Semaglutide
Semaglutide is a GLP-1 agonist used for weight loss, type 2 diabetes, and reducing cardiovascular ...
More about Inpefa (sotagliflozin)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: SGLT-2 inhibitors
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.